Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension

NCT01756430 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

238

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Carvedilol SR 32mg, QD
DRUG: Carvedilol SR 64mg, QD
DRUG: Carvedilol IR 25mg, QD
DRUG: Carvedilol IR 25mg, BID

Sponsor

Chong Kun Dang Pharmaceutical